TerrAscend (TSNDF) Non Operating Investment Income (2021 - 2025)
TerrAscend (TSNDF) reported Non Operating Investment Income of -$629000.0 for Q4 2025, down 2416.0% year-over-year from $27158.9 in Q4 2024, and down 62800.0% quarter-over-quarter from -$1000.0 in Q3 2025.
TerrAscend (TSNDF) Non Operating Investment Income (2021 - 2025) Analysis & Trends
TerrAscend (TSNDF) has 5 years of Non Operating Investment Income data on file, last reported at -$629000.0 in Q4 2025.
- Non Operating Investment Income for Q4 2025 came in at -$629000.0, down 2416.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$623000.0 (up 36.43% YoY), and the FY2025 annual result was -$1.4 million, down 473.53% from the prior year.
- Non Operating Investment Income eased to -$629000.0 in Q4 2025 per TSNDF's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $6.0 million in Q2 2021 and troughed at -$1.7 million in Q2 2023.
- A 5-year average of $126750.0 and a median of -$15000.0 in 2023 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Investment Income surged 380.0% in 2024, then tumbled 2416.0% in 2025.
- A 5-year view of Non Operating Investment Income shows it stood at $6.0 million in 2021, then tumbled by 99.23% to $46000.0 in 2022, then sank by 619.57% to -$239000.0 in 2023, then soared by 89.54% to -$25000.0 in 2024, then plunged by 2416.0% to -$629000.0 in 2025.
- Business Quant data shows TSNDF's Non Operating Investment Income at -$629000.0 in Q4 2025, -$1000.0 in Q3 2025, and $7000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | TerrAscend | - | - | 34.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -629,000.00 |
| Dec 31, 2025 | -629,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7,000.00 |
| Mar 31, 2025 | -742,000.00 |
| Mar 31, 2025 | -742,000.00 |
| Dec 31, 2024 | -25,000.00 |
| Dec 31, 2024 | -25,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | -227,000.00 |
| Jun 30, 2024 | -227,000.00 |
| Dec 31, 2023 | -239,000.00 |
| Dec 31, 2023 | -239,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -1.66 Mn |
| Jun 30, 2023 | -1.66 Mn |